Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Fitting

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 20, 2016
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex SlicesChangqing Xu, Douglas J Hermes, Ken Mackie, et al.
Journal of Neurochemistry|April 21, 2010
beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migrationYun Kyung Hahn, Phu Vo, Sylvia Fitting, et al.
Neuroimmune Pharmacology and Therapeutics|April 7, 2023
The link between chronic cocaine use, B cell perturbations, and blunted immune recovery in HIV-infected individuals on suppressive ARTDa Cheng, Zhenwu Luo, Sylvia Fitting, et al.
Cannabis and Cannabinoid Research|May 22, 2026
Longitudinal Analysis of Cannabinoid Type 1 Receptor in HIV-1 Tat Transgenic Mice Using PET Imaging and Western Blot AnalysisBarkha J Yadav-Samudrala, Brooke E Chapple, Spencer Thompson, et al.
Brain, Behavior, and Immunity|February 7, 2026
Effects of acute THC challenge on behavior and neuroinflammation in HIV-1 Tg26 mice vary based on HIV status, chronic THC history, and sexHavilah P Ravula, Barkha J Yadav-Samudrala, Laith E Sawaqed, et al.
The Journal of Pharmacy and Pharmacology|January 6, 2015
The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine modelKelstan Ellis, Jerry W Marlin, Tracey A H Taylor, et al.
Scientific Reports|August 6, 2016
HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous systemJoy Guedia, Paola Brun, Sukhada Bhave, et al.
Brain : a Journal of Neurology|November 22, 2011
Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing gliaShiping Zou, Sylvia Fitting, Yun-Kyung Hahn, et al.
European Journal of Pharmacology|June 5, 2012
Morphine efficacy is altered in conditional HIV-1 Tat transgenic miceSylvia Fitting, Krista L Scoggins, Ruqiang Xu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 22, 2011
Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strainElizabeth M Podhaizer, Shiping Zou, Sylvia Fitting, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 20, 2016
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex SlicesChangqing Xu, Douglas J Hermes, Ken Mackie, et al.
Journal of Neurochemistry|April 21, 2010
beta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migrationYun Kyung Hahn, Phu Vo, Sylvia Fitting, et al.
Neuroimmune Pharmacology and Therapeutics|April 7, 2023
The link between chronic cocaine use, B cell perturbations, and blunted immune recovery in HIV-infected individuals on suppressive ARTDa Cheng, Zhenwu Luo, Sylvia Fitting, et al.
Cannabis and Cannabinoid Research|May 22, 2026
Longitudinal Analysis of Cannabinoid Type 1 Receptor in HIV-1 Tat Transgenic Mice Using PET Imaging and Western Blot AnalysisBarkha J Yadav-Samudrala, Brooke E Chapple, Spencer Thompson, et al.
Brain, Behavior, and Immunity|February 7, 2026
Effects of acute THC challenge on behavior and neuroinflammation in HIV-1 Tg26 mice vary based on HIV status, chronic THC history, and sexHavilah P Ravula, Barkha J Yadav-Samudrala, Laith E Sawaqed, et al.
The Journal of Pharmacy and Pharmacology|January 6, 2015
The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine modelKelstan Ellis, Jerry W Marlin, Tracey A H Taylor, et al.
Scientific Reports|August 6, 2016
HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous systemJoy Guedia, Paola Brun, Sukhada Bhave, et al.
Brain : a Journal of Neurology|November 22, 2011
Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing gliaShiping Zou, Sylvia Fitting, Yun-Kyung Hahn, et al.
European Journal of Pharmacology|June 5, 2012
Morphine efficacy is altered in conditional HIV-1 Tat transgenic miceSylvia Fitting, Krista L Scoggins, Ruqiang Xu, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 22, 2011
Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strainElizabeth M Podhaizer, Shiping Zou, Sylvia Fitting, et al.
Pageof 8